Skip to main content
SpringerLink
Log in

ACMT Position Statement: Interpretation of Urine for Tetrahydrocannabinol Metabolites

  • Position Statement
  • Published:
Journal of Medical Toxicology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Office of the Federal Register of the United States, National Archives and Records Administration. Federal Register Vol. 82, No. 13. https://www.govinfo.gov/content/pkg/FR-2017-01-23/pdf/FR-2017-01-23.pdf Accessed May 2, 2019.

  2. Kulig K. Interpretation of workplace tests for cannabinoids. J Med Toxicol. 2017;13:106–10.

    Article  CAS  Google Scholar 

  3. Brahm NC, Yeager LL, Fox MD, Farmer KC, Palmer TA. Commonly prescribed medications and potential false-positive urine drug screens. Am J Health Syst Pharm. 2010;67:1344–50.

    Article  Google Scholar 

  4. Johnson-Davis KL, Sadler AJ, Genzen JR. A retrospective analysis of urine drugs of abuse immunoassay true positive rates at a national reference laboratory. J Anal Toxicol. 2016;40:97–107.

    Article  CAS  Google Scholar 

  5. Kapur BM. False positive drugs of abuse immunoassays. Clin Biochem. 2012;45:603–4.

    Article  Google Scholar 

  6. Saitman A, Park HD, Fitzgerald RL. False-positive interferences of common urine drug screen immunoassays: a review. J Anal Toxicol. 2014;38:387–96.

    Article  CAS  Google Scholar 

  7. Goodwin RS, Darwin WD, Chiang CN, Shih M, Li S, Huestis MA. Urinary elimination of 11-Nor-9-carboxy-9-tetrahydrocannabinol in cannabis users during continuously monitored abstinence. J Anal Toxicol. 2008;32:562–0.

    Article  CAS  Google Scholar 

  8. Shalit N, Barzilay R, Shoval G, Shlosberg D, Zweigenhaft N, Weizman A, et al. Characteristics of synthetic cannabinoid and cannabis users admitted to a psychiatric hospital: a comparative study. J Clin Psychiatry. 2016;77:e989–95.

    Article  Google Scholar 

  9. Nahler G, Grotenhermen F, Zuardi AW, Crippa JAS. A conversion of oral cannabidiol to delta9-tetrahydrocannabinol seems not to occur in humans. Cannabis Cannabinoid Res. 2017;1:81–6.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Emergency Medicine, Medical University of South Carolina, Charleston, SC, USA

    Nicholas Connors

  2. Palmetto Poison Center, Columbia, SC, USA

    Nicholas Connors

  3. University of Colorado School of Medicine, Aurora, CO, USA

    Michael J. Kosnett

  4. Toxicology Associates, Prof LLC, Denver, CO, USA

    Ken Kulig

  5. Rutgers New Jersey Medical School, Newark, NJ, USA

    Lewis S. Nelson

  6. Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Andrew I. Stolbach

Authors
  1. Nicholas Connors
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael J. Kosnett
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ken Kulig
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lewis S. Nelson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andrew I. Stolbach
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew I. Stolbach.

Ethics declarations

Disclaimer

While individual practices may differ, this is the position of the American College of Medical Toxicology at the time written, after a review of the issue and pertinent literature.

Conflict of Interest

None.

Additional information

Supervising Editor: Mark B. Mycyk, MD

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Connors, N., Kosnett, M.J., Kulig, K. et al. ACMT Position Statement: Interpretation of Urine for Tetrahydrocannabinol Metabolites. J. Med. Toxicol. 16, 240–242 (2020). https://doi.org/10.1007/s13181-019-00753-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13181-019-00753-8

Keywords

Search

Navigation